Reumatismo (Mar 2025)

After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?

  • Ciro Manzo,
  • Marco Isetta

DOI
https://doi.org/10.4081/reumatismo.2025.1823

Abstract

Read online

Dear Editor, the number of cases of cancer patients diagnosed as having immune checkpoint inhibitor-mediated polymyalgia rheumatica has been steadily rising in published reports. However, the lack of a validated scale or algorithm is still a relevant methodological limit in diagnosing this nosologic entity...

Keywords